Cargando…

Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors

Natural killer (NK) cells, key antitumor effectors of the innate immune system, are endowed with the unique ability to spontaneously eliminate cells undergoing a neoplastic transformation. Given their broad reactivity against diverse types of cancer and close association with cancer prognosis, NK ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Nayoung, Lee, Dong-Hee, Choi, Woo Seon, Yi, Eunbi, Kim, HyoJeong, Kim, Jung Min, Jin, Hyung-Seung, Kim, Hun Sik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Biochemistry and Molecular Biology 2021
Materias:	Invited Mini Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851441/ https://www.ncbi.nlm.nih.gov/pubmed/33298244 http://dx.doi.org/10.5483/BMBRep.2021.54.1.214

Ejemplares similares

Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2021)

CD19/CD22 bispecific chimeric antigen receptor‑NK‑92 cells are developed and evaluated
por: Kim, Hyori, et al.
Publicado: (2023)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020)

Filamin A Is Required for NK Cell Cytotoxicity at the Expense of Cytokine Production via Synaptic Filamentous Actin Modulation
por: Kim, Nayoung, et al.
Publicado: (2022)

GSK-3α Inhibition in Drug-Resistant CML Cells Promotes Susceptibility to NK Cell-Mediated Lysis in an NKG2D- and NKp30-Dependent Manner
por: Kim, Nayoung, et al.
Publicado: (2021)

Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies
por: Zhao, Qi
Publicado: (2019)

Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy
por: Kwon, Hyung-Joon, et al.
Publicado: (2017)

Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
por: Kim, Nayoung, et al.
Publicado: (2018)

Structural studies of serotonin receptor family
por: Parajulee, Apeksha, et al.
Publicado: (2023)

Assessment of NK Cell Activity Based on NK Cell-Specific Receptor Synergy in Peripheral Blood Mononuclear Cells and Whole Blood
por: Kim, Jung Min, et al.
Publicado: (2020)

Clinical significance linked to functional defects in bone morphogenetic protein type 2 receptor, BMPR2
por: Kim, Myung-Jin, et al.
Publicado: (2017)

Suicide Gene Therapy to Increase the Safety of Chimeric Antigen Receptor-Redirected T Lymphocytes
por: Casucci, Monica, et al.
Publicado: (2011)

Deep sequencing of B cell receptor repertoire
por: Kim, Daeun, et al.
Publicado: (2019)

Structure biology of selective autophagy receptors
por: Kim, Byeong-Won, et al.
Publicado: (2016)

Emerging role of transient receptor potential (TRP) channels in cancer progression
por: Yang, Dongki, et al.
Publicado: (2020)

Odorant receptors in cancer
por: Chung, Chan, et al.
Publicado: (2022)

Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
por: Wang, Xiao, et al.
Publicado: (2022)

G protein-coupled receptors in stem cell maintenance and somatic reprogramming to pluripotent or cancer stem cells
por: Choi, Hye Yeon, et al.
Publicado: (2015)

Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy
por: Shin, Seungyong, et al.
Publicado: (2023)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7
por: Kim, Ji-Hae, et al.
Publicado: (2021)

Intestinal organoids as advanced modeling platforms to study the role of host-microbiome interaction in homeostasis and disease
por: Ahn, Ji-Su, et al.
Publicado: (2023)

2-Undecanone derived from Pseudomonas aeruginosa modulates the neutrophil activity
por: Jeong, Yu Sun, et al.
Publicado: (2022)

Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
por: Zhang, Jianguang, et al.
Publicado: (2019)

Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
por: Lee, Maxwell Y, et al.
Publicado: (2021)

Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
por: Cartellieri, Marc, et al.
Publicado: (2010)

Chimeric antigen receptor T cell: A cancer immunotherapy
por: Singh, Surjit, et al.
Publicado: (2022)

BLT2, a leukotriene B(4) receptor 2, as a novel prognostic biomarker of triple-negative breast cancer
por: Park, JaeIn, et al.
Publicado: (2018)

Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas: a systematic analysis and review
por: Cho, Hee Jin, et al.
Publicado: (2021)

Metabolic regulation of NK cell function: implications for immunotherapy
por: Sohn, Hyogon, et al.
Publicado: (2023)

Odorant Receptor Desensitization in Insects
por: Guo, Hao, et al.
Publicado: (2017)

Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy
por: Jin, Hyung-seung, et al.
Publicado: (2021)

NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development
por: Bashiri Dezfouli, Ali, et al.
Publicado: (2021)

Dead cell phagocytosis and innate immune checkpoint
por: Yoon, Kyoung Wan
Publicado: (2017)

MicroRNA controls of cellular senescence
por: Suh, Nayoung
Publicado: (2018)

Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
por: Hegde, Upendra P., et al.
Publicado: (2017)

Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer
por: Shang, Yufeng, et al.
Publicado: (2019)

Oxygen matters: hypoxia as a pathogenic mechanism in rhinosinusitis
por: Cho, Hyung-Ju, et al.
Publicado: (2018)

Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
por: Sivori, Simona, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_96gcfimgrn1cdmn788e5b96ml9